New patent for the Azurity drug KONVOMEP – DrugPatentWatch
Annual Drug Patent Expiration for KONVOMEP
Konvomep is a drug marketed by Azurity and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
This drug has four patent family members in four countries.
The generic ingredient in KONVOMEP is omeprazole; sodium bicarbonate. One registered supplier for this compound. Additional details are available on omeprazole; sodium bicarbonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the Azurity drug KONVOMEP
